Home › MannKind shares rise 10% after insulin drug Afrezza OKd by FDA
 

Keywords :   


MannKind shares rise 10% after insulin drug Afrezza OKd by FDA

2014-07-01 05:02:03| Biotech - Topix.net

Afrezza is a powder insulin that is inhaled through a handheld device. A quick puff would replace an insulin injection that patients with diabetes now use to regulate blood glucose levels.

Tags: by drug rise shares

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05New ACA-Published Industry Market Analysis for the Paint & Coatings Industry Now Available
20.05Ulta Beauty Launches Same-Day Delivery with DoorDash
20.05Nivea Crmes Limited-Edition Pride Tin Heralds New Initiative with PFLAG
20.05Sheboygan Paint Company Appoints New Technical Sales Representative
20.05Scentair Adds Two Odor-Neutralizing Fragrances to its Auto Line Up
20.05GK Hair Unveils Summer 2024s Must-Have Hair Trends
20.05Revlon Taps Under Armour\'s Tchernavia Rocker As New Chief People Officer
20.05Canada invests over $9.6M to prevent, prepare for African swine fever
More »